Definitive Contract 75A50124C00023
Award Date 7/1/24
Potential Completion Date 1/9/26
Potential Value $631K
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Redwood City, CA 94065, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed price purchase order awarded by the Defense Health Agency (DHA) to Karius, Inc. for quantitative next-generation sequencing testing services. The $240,000 contract supports DHA programs through September 2023 and leverages Karius' expertise in genomic sequencing to rapidly screen patients for various pathogens. This is a sole source award, as Karius is the only commercial laboratory capable of providing the requested cell-free DNA testing from plasma samples with 24-72...
- This contract was awarded by the National Institutes of Health (NIH) Clinical Center to Karius, Inc., a life sciences company specializing in diagnostic testing for infectious diseases. The contract, valued at $80,000.00, is for the provision of molecular diagnostic testing services using Karius' liquid biopsy technology to rapidly screen patients for various pathogens. The testing services will be delivered within 3-4 days of specimen receipt. This is a firm fixed-price purchase order...
- The Department of the Navy Bureau of Medicine and Surgery awarded a $140,000 firm fixed price purchase order to Karius, Inc. for the provision of 70 quantitative next generation sequencing tests. This award is not associated with a larger contract vehicle and does not have a set-aside designation. Karius, Inc. is a life sciences company focused on diagnostic testing for infectious diseases. The purchase order supports Department of Defense programs through September 2027 and leverages Karius'...
- The Defense Health Agency (DOD) awarded a $250,000 firm fixed price purchase order to Karius, Inc., doing business as Karius Inc., located in San Diego, California. The contract is for Quantitative Next-Gen Sequencing Testing Services and has a period of performance from October 1, 2022 through September 30, 2023. Karius provides genomic sequencing and bioinformatics analysis services to identify pathogens and monitor antimicrobial resistance. No applicable subcontractors were identified in...
- This is a federal contract award to Karius, Inc., a life sciences company specializing in next-generation sequencing (NGS) and molecular diagnostic testing services. The contract, awarded by the U.S. Department of Veterans Affairs (VA), is an Indefinite Delivery Contract (IDC) valued at up to $120,000,000. Under this IDC, the VA can purchase Karius' KARIUS NEXT GENERATION SEQUENCING TEST at $2,000 per test, with Karius identified as the sole responsible source. The contract has a period of...
- On April 1, 2025, the Department of Veterans Affairs, Veterans Integrated Service Network 17, awarded a delivery order valued at $22,000 to Karius, Inc. under contract 36C25725D0031 (Order #36C25725N0219). This firm fixed-price delivery order, with an ultimate completion date of March 31, 2026, represents performance at the contractor's location in Harlingen, Texas. The award was issued without set-aside designation and leverages Karius, Inc.'s specialized capabilities in next-generation...
- Karius, Inc. has been awarded a $22,000 delivery order by Veterans Integrated Service Network 17 (VISN 17), a civilian agency within the Department of Veterans Affairs, for its Karius Next Generation Sequencing Test. The contract, issued on April 1, 2026, with an ultimate completion date of March 31, 2027, represents a firm fixed-price delivery order without a set-aside designation. The place of performance is located in Redwood City, California, where Karius, Inc. maintains its headquarters....
- This federal contract award is for a Quantitative Next-Gen Sequencing Test to be provided to the Naval Medical Center San Diego Lab Department. The $240,000.00 firm fixed-price purchase order was awarded to Karius, Inc., a life sciences company specializing in advanced molecular diagnostic testing and next-generation sequencing technologies. The contract, which does not have a set-aside designation, has an ultimate completion date of September 30, 2027 and was awarded on October 1, 2023....
- This is a federal contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency, to Pattern Bioscience, Inc., a biotechnology company, to develop a rapid pathogen identification and antimicrobial susceptibility testing platform. The contract, valued at $40,937,536.73, is for the verification, clinical evaluation, and U.S. Food and Drug Administration (FDA) clearance of this culture-free, phenotypic diagnostic platform. The contract is a...
- This is a Firm Fixed Price contract awarded by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response (ASPR) to Janus-I Science Inc., a self-certified small disadvantaged business. The contract, valued at $710,619.00, is for Direct RNA Sequencing of Emerging Respiratory Agents and Host Response, under the JANUS-I program. This contract was awarded on April 15, 2019, with a completion date of October 14, 2020. It was not set aside for any...